Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma. | Int J Gen Med | 2023 | 37916194 | PubTator, text mining | PubMed |
| Role of Resolvins in Inflammatory and Neuropathic Pain. | Pharmaceuticals (Basel) | 2023 | 37895837 | PubTator, text mining | PubMed |
| IL-20 Cytokines Are Involved in the Repair of Airway Epithelial Barrier: Implication in Exposure to Cigarette Smoke and in COPD Pathology. | Cells | 2023 | 37887308 | PubTator, text mining | PubMed |
| "Input/output cytokines" in epidermal keratinocytes and the involvement in inflammatory skin diseases. | Front Immunol | 2023 | 37881433 | PubTator, text mining | PubMed |
| Immunological role and clinical prognostic significance of P2RY6 in lung adenocarcinoma: a multi-omics studies and single-cell sequencing analysis. | World J Surg Oncol | 2023 | 37880703 | PubTator, text mining | PubMed |
| The role of mitochondria-related lncRNAs in characterizing the immune landscape and supervising the prognosis of osteosarcoma. | J Bone Oncol | 2023 | 37868616 | PubTator, text mining | PubMed |
| The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37867531 | PubTator, text mining | PubMed |
| Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer. | Aging (Albany NY) | 2023 | 37862114 | PubTator, text mining | PubMed |
| Identification of Plasma Inflammatory Markers of Adolescent Depression Using the Olink Proteomics Platform. | J Inflamm Res | 2023 | 37849645 | PubTator, text mining | PubMed |
| Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37835465 | PubTator, text mining | PubMed |
| Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. | Mol Cancer | 2023 | 37833788 | PubTator, text mining | PubMed |
| Dental pulp stem cells accelerate wound healing through CCL2-induced M2 macrophages polarization. | iScience | 2023 | 37829207 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| Hyperuricemia remodels the serum proteome toward a higher inflammatory state. | iScience | 2023 | 37810213 | PubTator, text mining | PubMed |
| Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response. | Front Immunol | 2023 | 37809098 | PubTator, text mining | PubMed |
| Proteomic profiling identifies novel inflammation-related plasma proteins associated with ischemic stroke outcome. | J Neuroinflammation | 2023 | 37794467 | PubTator, text mining | PubMed |
| Interferons-Implications in the Immune Response to Respiratory Viruses. | Microorganisms | 2023 | 37764023 | PubTator, text mining | PubMed |
| Defining the Basal and Immunomodulatory Mediator-Induced Phosphoprotein Signature in Pediatric B Cell Acute Lymphoblastic Leukemia (B-ALL) Diagnostic Samples. | Int J Mol Sci | 2023 | 37762241 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
| TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes. | Redox Biol | 2023 | 37757542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=10